drugset / Trial / NCT04570345

3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI

NCT04570345 ↗

Phase 4 Unknown 1002 enrolled Dong-A University
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the clinical outcomes of dual antiplatelet therapy with aspirin and P2Y12 receptor inhibitor vs. ticagrelor monotherapy at 3 months after PCI in patients with ST-elevation myocardial infarction.

Timeline

Start
2021-01-01
Primary completion
2021-08-31
Completion
2022-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule — —
Subject Ticagrelor Small molecule — —